Collaboration. Acceleration. Results.      1 877 TO FIX MS
Myelin Repair Foundation Home Page Donate to Myelin Repair Foundation
Mission: To transform the way all medical research is done — ensuring research results in real patient treatments in the shortest amount of time.

Our Research Model

We are the only research organization that addresses every phase in the drug discovery process, from initial research all the way to the clinic, in order for new treatments to reach patients.

The Myelin Repair Foundation's Accelerated Research Collaboration™ (ARC™) model addresses every phase in the drug discovery continuum, from initial research all the way to licensing by commercial drug developers. Through the Myelin Repair Foundation’s ongoing management oversight, the ARC model optimizes and integrates the contributions of all those who participate in the value chain of making new medicines.

As a result, the Myelin Repair Foundation’s ARC model:

  • Provides an increased number of therapeutically relevant treatment targets in the pipeline
  • Translates discoveries made in animal models to the human system
  • Builds partnerships with biopharma companies to develop and bring new drugs to market and
  • Results in quicker, effective treatments for millions of patients living with chronic diseases, improving their quality of life

The Accelerated Research Collabortation™ (ARC™) Model

Click each section to learn more about the Myelin Repair Foundation's ARC model. To read more, visit these pages: Discovery Biology | Translational Medicine Platform | Clinical Development

Patient Outcomes
Clinical Development
Clinical Development
Clinical Development
Translational Medicine Platform
Translational Medicine Platform
Translational Medicine Platform
Discovery Biology
Discovery Biology
Discovery Biology

What Others are Saying

“[The Myelin Repair Foundation’s approach] could result in a promising future for big pharma, a sustainable future for the biomedical innovation ecosystem, and most importantly, a healthier future for patients.”

The Atlantic
April 2012


Accelerate Treatments to MS Patients

Your support will help us deliver a first-in-class myelin repair treatment to multiple sclerosis patients as rapidly as possible. Donations at all levels are critical to achieving this mission.

Donate Now

Keep Updated On Our Progress

Sign Up for Email Updates